Phenotype of SARS-CoV-2-specific T-cells in COVID-19 patients with acute respiratory distress syndrome

Daniela Weiskopf; Katharina S. Schmitz; Matthijs P. Raadsen; Alba Grifoni; Nisreen M.A. Okba; Henrik Endeman; Johannes P.C. van den Akker; Richard Molenkamp; Marion P.G. Koopmans; Eric C.M. van Gorp; Bart L. Haagmans; Rik L. de Swart; Alessandro Sette; Rory Dylan de Vries.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20062349

Documentos relacionados

  1. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.
  2. Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4<sup>+</sup> T cell recognition.
  3. Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells.
  4. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.
  5. Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity.
  6. The T cell immune response against SARS-CoV-2.
  7. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
  8. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
  9. Vaccinated and Convalescent Donor-Derived Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients.
  10. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.